Shanghai Fosun Pharmaceutical(Group) Co.,Ltd.’s Net Profit Dropped 29.1% in First Three Quarters of 2022

Shanghai Fosun Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) (600196.SH) reported a net profit of 2.8 billion yuan in the first three quarters of 2022, down 29.1% year-on-year.

Meanwhile, the company posted 31.6 billion yuan in revenue, up 16.9% year-on-year.

At the end of the reporting period, it had 104.3 billion yuan in total assets and 51.1 billion yuan in total liabilities, with a liability-to-asset ratio of 49%.